Cargando…
Prognostic significance of factor XIIIA promoter methylation status in aneurysmal subarachnoid haemorrhage (aSAH)
BACKGROUND: Aneurysmal subarachnoid hemorrhage is a life- threatening condition with high rate of disability and mortality. Apolipoprotein E (APOE) and Factor XIIIA (F13A) genes are involved in the pathogenetic mechanism of aneurysmal subarachnoid haemorrhage (aSAH). We evaluated the association of...
Autores principales: | Arati, S., Chetan, G. K., Sibin, M. K., Bhat, Dhananjaya I., Vazhayil, Vikas, Narasingarao, K. V. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637610/ https://www.ncbi.nlm.nih.gov/pubmed/31315570 http://dx.doi.org/10.1186/s12872-019-1146-8 |
Ejemplares similares
-
Factor XIII polymorphism and risk of aneurysmal subarachnoid haemorrhage in a south Indian population
por: Suvatha, Arati, et al.
Publicado: (2018) -
Polymorphisms of apolipoprotein E and aneurysmal subarachnoid haemorrhage: A meta-analysis
por: Arati, S., et al.
Publicado: (2016) -
Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom
por: Rivero-Arias, Oliver, et al.
Publicado: (2010) -
Neuroprotective Strategies in Aneurysmal Subarachnoid Hemorrhage (aSAH)
por: Weiland, Judith, et al.
Publicado: (2021) -
Acute Multidisciplinary Management of Aneurysmal Subarachnoid Hemorrhage (aSAH)
por: Ran, Kathleen R, et al.
Publicado: (2023)